This topic contains a solution. Click here to go to the answer

Author Question: The nurse is caring for a patient with ulcerative colitis who is being treated with azathioprine. ... (Read 56 times)

vHAUNG6011

  • Hero Member
  • *****
  • Posts: 514
The nurse is caring for a patient with ulcerative colitis who is being treated with azathioprine. Which laboratory test result should be monitored periodically?
 
  a. Microscopic urine examination
  b. Complete blood count (CBC) with differential
  c. Immunoglobulin survey
  d. Serum albumin

Question 2

The nurse is teaching a pharmacology refresher class to a group of medical-surgical nurses. The nurse asks Alosetron (Lotronex) is approved for which patient population?
 
  Which response by one of the nurses best indicates understanding of the use of this drug?
  a. It has been approved for use in women with diarrhea-predominant IBS.
  b. It can be given to men with diarrhea and crampy abdominal pain due to IBS.
  c. It would be indicated for pregnant women with iron-associated constipation.
  d. It is approved for use in children whose growth rate is reduced because of IBS.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dnite

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

ANS: B
The nurse should monitor the CBC, because neutropenia is a major adverse effect of azathioprine. Another major adverse effect is pancreatitis.
Microscopic urinalysis is not indicated.
The immunoglobulin and serum albumin levels do not require monitoring.

Answer to Question 2

ANS: A
Alosetron is approved for use in women only with diarrhea-predominant IBS; this statement indicates understanding.
Alosetron is not approved for symptoms of IBS in men, only women; further teaching is needed.
Alosetron is approved only for use in women with IBS associated with diarrhea. It therefore would be contraindicated in pregnant women with iron-associated constipation and children with IBS; further teaching is needed.




vHAUNG6011

  • Member
  • Posts: 514
Reply 2 on: Jul 23, 2018
Wow, this really help


pratush dev

  • Member
  • Posts: 321
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

For a complete list of videos, visit our video library